Organization's List of Essential Medicines which comprises the safest and most 48 effective medicines needed in global health systems. Although it has been widely 49 applied as a disinfectant and antiseptic since the 1950s in healthcare (skin, hands, 50 mouthwashes, eye drops), its use in hospitals to prevent nosocomial infections has 51 increased worldwide in recent years. Here we provide a comprehensive study on 52 chlorhexidine tolerance among Enterococcus faecium, one of the leading nosocomial 53 agents worldwide, and identified a novel 2CS-CHX T operon as a signature of tolerant 54 strains occurring in diverse phylogenomic groups. Finally, our data allowed to propose 55 a tentative epidemiological cut-off of 8 mg/L, useful to detect tolerant E. faecium 56 populations in future surveillance studies in community and clinical contexts. Chlorhexidine is one of the substances included in the World Health Organization's List 66 of Essential Medicines which comprises the safest and most effective medicines needed 67 in global health systems (1). It is a cationic biguanide acting in bacteria by binding to 68 cell wall and membrane anionic sites and affecting the osmotic equilibrium of the cell. 69
At elevated concentrations, as used in antimicrobial marketed products, it causes the 70 loss of membrane structural integrity, resulting in cell death (2, 3) . Chlorhexidine is 71 widely used as a topical antiseptic in the community (e.g., oral care, skin antisepsis, 72 cosmetics), in veterinary (e.g., skin antisepsis, teat dips, udder and eye wash) and 73 hospitals (e.g., hand hygiene, daily patient baths, impregnated wash cloths, impregnated 74 cardiovascular catheters, oral antisepsis) with concentrations varying between 0.05-4% 75 (corresponding to 500-40,000 mg/L) (3) (4) (5) (6) . Although chlorhexidine is in the market 76 since the 1950's, it has been increasingly used in the last decade in the hospital setting 77 to prevent catheter-related bloodstream infections, ventilator associated pneumonia, 78 skin soft infections or patients' skin colonization by multidrug resistant bacteria 79 included in high priority WHO list, as methicillin-resistant Staphylococcus aureus 80 (MRSA) or vancomycin resistant Enterococcus (VRE) (4, (7) (8) (9) (10) 81 https://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-82 ET_NM_WHO.pdf). 83
Enterococcus faecium is one of the species most commonly associated with nosocomial 84 infections worldwide in the last years, with clinical isolates often being resistant to first-85 line antibiotics, ampicillin and vancomycin (11) . Despite the high transmissibility of E. 86 faecium strains in health care institutions, few studies have evaluated the chlorhexidine 87 activity against this species. Most of them focused on E. faecium from a single source 88 (either clinical, animal or food) (12-19), did not consider strain's genetic background 89 (12-14, 16, 17, 19, 20) or included a low number of isolates (14-17), precluding the 90 analysis of chlorhexidine susceptibility data in the context of E. faecium population 91 structure. 92
The genotypes or expression profiles of E. faecium isolates showing chlorhexidine 93 tolerance have been scarcely explored (13, (21) (22) (23) . Tolerance phenotypes were related 94 to a unique, nonsynonymous single amino acid polymorphism (P102H) in a conserved 95 DNA-binding response regulator ChtR in three strains from clade A1 of clinical origin, 96 which along with a histidine kinase sensor ChtS formed a regulator system called 2CS 97 with an unknown regulon. The advantage of ChtR-P102H mutation for E. faecium was 98 demonstrated by molecular (mutants with ChtR/ChtS deletion and trans 99 complementation) and phenotypic studies involving growth curves in the presence of 100 1.2 mg/L of chlorhexidine (21). Also, the occurrence of A290V amino acid change in 101 EfrE protein (codifying for predicted ABC transport system) detected in mutants 102 generated after 21 days of passages in culture media supplemented with sub-inhibitory 103 chlorhexidine concentrations was again detected in a clade A1 E. faecium (wild type: 104 MIC=4,9 mg/L; mutants: MIC=19,6 mg/L) (23). Among Gram-positive bacteria, cross-105 tolerance to quaternary ammonium compounds and chlorhexidine was suggested to be 106 associated to qacA/B gene in Staphylococccus spp. (24, 25) , with the limited data for E. 107 faecium (17, 26) impairing to assess the potential role of this or other qac/smr genes in 108 chlorhexidine tolerance among this species. 109
This study provides new phenotypic and molecular data for a better identification of 110 chlorhexidine tolerant E. faecium subpopulations in community and clinical contexts. It 111 is demonstrated that tolerant E. faecium are spread in different sources and 112 phylogenomic groups with predominance in clade A1, and that they carry a genetically 113 stable 2CS-CHX T operon, here identified. The combined phenotypic and molecular data 114 clade B of 0.00014%. In both cases, the probability of occurrence of an isolate with 141 MIC CHX >16 mg/L was of 0%. Contrasting with these data, the distribution of E. faecium 142 from clade A2 was bimodal (modes at 4 mg/L-30% and 16 mg/L-37% of 43 isolates of 143 clade A2), suggesting the occurrence of two subpopulations ( Fig. 1-IIIa) . The limit of 144 95% of wild type population of the clade A2 was proposed as 8 mg/L by the 145 ECOFFinder tool with the probability of a wildtype isolate to have a MIC CHX >4 and 146 ≤8mg/L being of 2.1% and MIC>8 mg/l of 0%. The analysis of the distribution data and 147 the probability of occurrence of wild type isolates in diverse MIC CHX of clades A2 and 148 B suggests a tentative ECOFF of 8 mg/L for E. faecium. 149
Minimum bactericidal concentrations of chlorhexidine (MBC CHX ) ranged between 16-150 128mg/L with MBC95 and MBC99=128 mg/L ( Table 1 ). The highest MBC CHX of 128 151 mg/L was observed in 51% (n=54/106) of the isolates studied, belonging to all clades, 152 diverse sources and presenting MIC CHX <2-32mg/L. Of note, isolates associated with 153 human infections (n=40; clades A1, A2, B) showed the same MBC95 and MIC99=128 154 mg/L than those not associated with human infections (n=66; clades A1, A2, B). When 155 microdilution assays were performed at pH=5, MBC CHX values increased 1-to 4-fold 156 dilutions for 32 isolates out of 37 tested comparing to MBC CHX in standard conditions. 157
For 27 E. faecium the MBC CHX increased to 256 mg/L ( The P102H mutation of the ChtR protein sequence, previously described to be 172 associated with clorhexidine tolerance (21), was detected in 26 of the 37 (70%) 173 genomes studied here, which were recovered from isolates of disparate sources 174 (hospitalized patients, n=14; patient at long-term-care-facility, n=1; healthy human, 175 n=1; piggeries, n=2; food of animal origin, n=6; wild birds, n=2) and phylogenomic 176 groups (clades A1: 69%, n=18; A2: 27%, n=7; B: 4%, n=1). Isolates without such 177 mutation were mostly from non-clinical origins (n=9 out of 11) and belong to clades A2 178 (64%, n=7; including two clinical isolates), B (27%, n=3) and A1 (9%, n=1). 179
Similar results were found among the 794 genomes analysed and published at the 180 GenBank database (Tables S3 and S4 ). It was verified that 71% (n=562/794) presented 181 the ChtR-P102H mutation, mostly associated with the clade A1 (79%, n=445/562), 182 followed by clade A2 (20%, n=113/562) and clade B (1%, n=4/562) (p<0.05; Chi 183 square test; GraphPad Prism version 8.0). Among the 232 genomes without the ChtR-184 P102H, most were from clade A2 (73%, n=170/232) followed by clade B (18%, 185 n=42/232) and clade A1 (9%, n=20/232). 186 187 Identification of the operon regulated by the ChtR protein and its association with 188 chlorhexidine tolerance phenotype. 189
The DOOR software predicted that the chtR gene was part of an operon with a length of 190 4086 bp, containing a histidine kinase sensor (chtS), previously described by , and genes coding for proteins related to a glucose:proton symporter 192 GlcU [superfamily (cl26915) The MIC CHX of isolates carrying the ChtR-P102H mutation ranged from 4 to 32 mg/L, 204 with 81% of them showing a MIC CHX ≥16 mg/L (14 from clade A1, 6 from clade A2, 1 205 from clade B), followed by 15% with MIC CHX =8 mg/L (3 from clade A1, 1 from A2) 206 and 4% with MIC CHX =4mg/L (1 isolate from clade A1). The isolates without the P102H 207 mutation presented MIC CHX ranging from <2 to 16 mg/L, with 73% (n=8/11; 5 from 208 clade A2 and 3 from B) showing a MIC CHX ≤4 mg/L, 18% (n=2/11; 1 from each clade 209 A1 and A2) a MIC CHX =16 mg/L and 9% (n=1/11; clade A2) a MIC CHX =8 mg/L (Table  210 2). These results point for a higher ChtR-P102H occurrence in isolates with a 211 MIC CHX ≥8mg/L (p<0.05; Fisher exact test; GraphPad Prism version 8.0). The analysis 212 of the sequences of the 37 E. faecium genomes from this study showed that those 213 carrying the P102H mutation in the ChtR (n=26) presented a 2CS-CHX T operon 214 sequence identity with the reference strain E. faecium E1162 (Table 2) , and all but one 215 isolate showed a MIC CHX ≥8 mg/L. A higher variability was observed among those 2CS-216 CHX T operons not carrying the ChtR-P102H mutation, mostly on those isolates with a 217 MIC CHX ≤4mg/L. In this group, diverse mutations in promoter, sensor histidine kinase, 218 glucose transporter or amino acid permease were observed (Table 2) . No clear 219 differences were observed in MBC CHX among isolates carrying or not the ChtR-P102H 220 mutation, both in standard and pH=5 adjusted conditions. 221 222
Detection of A290V mutation in EfrE protein and the occurrence of qac/smr genes. 223
The A290V mutation in EfrE protein was not detected in any isolated analysed, even on 224 those isolates with MIC CHX >16 mg/L, contrasting with laboratory generated isolates 225 with this phenotype (23). This mutation was also absent in the selected 980 E. faecium 226 genomes published at the GenBank database with EfrR protein identified. 227
A hospital sewage E. faecium carrying qacZ gene (27) The increasing use of chlorhexidine in recent years foresees an evolution of bacterial 234 populations towards tolerance, imposing the need to identify chlorhexidine wild type E. 235 faecium populations to better establish epidemiological cutoffs (ECOFFs) for 236 susceptibility surveillance studies. An ECOFF (MIC) to chlorhexidine of ≤32 mg/L was 237 recently proposed by Morrissey et al. (20) . However, our analysis of these authors´ 238 results by using the ECOFFinder tool (data not shown) suggests the presence of a 239 tolerant population by a fitted curve slightly deviated to the left comparing to raw data 240 distribution, as in the case of our 106 isolates, and thus an overestimation of the 241 proposed ECOFF. The bimodal distribution of E. faecium within clade A2 in our study 242 also supports the presence of tolerant populations. The occurrence probability of 0% or 243 almost 0% (NORM.DIST function) of E. faecium with MIC CHX >8 mg/L within clades 244 A2 or B, respectively, suggests a tentative ECOFF of 8mg/L, although it classifies most 245 of clade A1 isolates as tolerant (81%; MIC=16-32mg/L). Clade A1 subpopulation is 246 predominant in the hospital setting where the great use of chlorhexidine could be 247 favouring their evolution towards tolerance to this antiseptic, as occurred among 248
Staphylococcus spp. causing human infections (28, 29) . A bias imposed by the high 249 number of isolates from clade A1 in our study, could have influenced the initial 250
proposal of the ECOFFinder tool of an ECOFF=32 mg/L for the 106 E. faecium as well 251 as the ECOFF=32 mg/L proposed in Morrissey et al. (20) study, in which the E. faecium 252 genetic background was not described. Such bias might also justify variable data among 253 studies associating chlorhexidine tolerance with vancomycin resistance and not 254 considering strains genetic background (16, 18, 19) . In fact, ampicillin resistance, and 255 not vancomycin, is an important marker of clade A1 strains (30), which explains the 256 higher MIC99 CHX among E. faecium resistant to ampicillin observed in our study. 257
The analysis of genotypes associated with chlorhexidine tolerance showed that ChtR-258 P102H mutation is mostly present in isolates with a MIC CHX ≥8 mg/L from any clade 259 and recovered from different sources, contrasting with previous descriptions only in 260 clade A1 E. faecium (21). The more antique strains with ChtR-P102H mutation found 261 in available genomes were from clade A2 and recovered from milk and dairy utensils 262 (USA, 1927) , a mouse (The Netherlands, 1959) , human clinical isolates (The 263 Netherlands, 1960 -1965 and others of non-identified source and origin (≤1946). Data 264 from our and published genomes suggest that independent ChtR-P102H mutation 265 acquisition could have occurred in isolates from different genetic and epidemiological 266 backgrounds. However, the main presence of ChtR-P102H in isolates from clade A1, 267 again supports the adaptation of this subpopulation towards chlorhexidine tolerance. 268
Clade A1 strains from 1987 (UK) and early 1990´s (USA, France) are the oldest and 269 within the time frame of the emergence of this population in the hospital setting (30). 270
Nevertheless, a careful analysis is necessary, as bias associated with published genomes 271 should be considered. 272
The new genes here predicted to be regulated by the ChtR and to complete the new 273 2CS-CHX T operon code for a second carrier symport glucose/H+ transporter (GlcU 274 type), and a permease of the APC family, which seem to be associated with gamma-275 aminobutyric acid (GABA) or other amino acids transport. The GlcU is widespread in 276
Firmicutes (31) and is a member of the prokaryote glucose/ribose porter family, 277 belonging to the drug metabolite superfamily of transporters (32). The one found in E. 278 faecium has 52% of amino acidic identity with those of Lactococcus lactis M1363 279 (GenBank: CAL99123.1), described to be a glucose uptake transporter dependent of 280 proton-motive force, which is preferentially expressed when environmental conditions 281 inhibit the high affinity-glucose uptake systems sugar phosphoenolpyruvate-282 phosphotransferases systems (PEP-PTS) (31). In different Firmicutes low 283 concentrations of chlorhexidine inhibit the PEP-PTS system (31, 33-36). Among 284
Streptococcus spp. sugar metabolism continues by a sugar-uptake system driven by 285 proton motive force insensitive to this antiseptic (33, 34), which seems to have a higher 286 expression at high rates of bacterial growth or acidic pH (37). Assuming that 287 chlorhexidine inhibits PEP-PTS systems in E. faecium as in other Firmicutes and 288 considering that the chlorhexidine susceptibility assays were performed in the 289 exponential phase when a high-rate growth occurs, it seemed that the GlcU transporter 290 could have an important role in the uptake of glucose for the bacterial cell survival 291 under chlorhexidine stress. Finally, the amino acid permease was identified as 292 belonging to the APC family, type GabP, which in some bacteria is induced by nitrogen 293 limited culture conditions (38) . We hypothesize that 2CS-CHX T operon could 294 contribute to a more effective energy associated metabolism used by the cell to cope 295 with sub-inhibitory concentrations of chlorhexidine, although functional studies 296 associated with each gene of the operon are still needed. It is of note that every time 297
ChtR-P102H mutation is present, the 2CS-CHX T sequence was the same among isolates 298 from all clades, contrasting with the variable mutations in all operon genes and/or the 299 promotor in E. faecium without the ChtR-P102H and with a MIC CHX ≤4mg/L. The 300 potential fixation of a stable 2CS-CHX T operon with the ChtR-P102H mutation in 301 isolates with higher MIC CHX values suggests a role of this operon for chlorhexidine 302 tolerance and that it could have contributed to the adaptation of particular 303 subpopulations, as clade A1 in hospitals. The 2CS-CHX T with the ChtR-P102H 304 mutation could also have importance in other stress contexts, still unexplored, as 305 pointed by its wide distribution as well as occurrence in strains collected before the 306 introduction of chlorhexidine, which was commercialized in 1954. 307
In our study the acid pH=5 increased the MBC CHX in several isolates. However, the 308 lack of correlation between this higher MBC and 2CS-CHX T variants suggests that 309 other mechanisms of tolerance to stress, namely in response to acid pH, might 310 contribute to higher survival of E. faecium to chlorhexidine in different conditions and 311 contexts (e.g. survival of particular strains in the skin with pH=4-6) (39). Cross 312 tolerance between acidic pH (pH=5.5) and chlorhexidine was also described to some 313 Streptococcus mutans mutants, which seemed to be associated to changes in membrane 314 fatty acids profiles (40). 315
The absence of the A290V mutation in the EfrE protein in all genomes analysed (our 37 316 E. faecium and available at GenBank database) indicates that A290V is not expected to 317 often occur in wild type strains, namely in those with higher MIC/MBC CHX (23). 318
Moreover, the MIC/MBC CHX values observed were not correlated with the presence of 319 qac/smr genes analysed among E. faecium. 320
In conclusion, the previously proposed ECOFF (MIC) of 32mg/L for chlorhexidine (20) 321 seems to be overestimated for E. faecium populations and our analysis of MIC CHX 322 normal distribution suggest a tentative ECOFF of 8 mg/L. However, the occurrence of 323 the ChtR-P102H in E. faecium with MIC CHX =8mg/L, of few isolates without such 324 mutation but with high MIC CHX values and the lack of correlation between MBCs and 325 2CS-CHX T variants underline the need of more studies to better understand E. faecium 326 chlorhexidine tolerance mechanisms. The data also suggest that E. faecium from clade 327 A1 is a more evolved population towards chlorhexidine tolerance, probably adapted to 328 the high use of this antiseptic in the clinical setting. Independently of E. faecium clades 329 or antibiotic susceptibility profile, our and other author's data show that E. faecium have 330 lower MBC CHX (e.g. 256 mg/L) than concentrations used in marketed biocidal products 331 (e.g. 4% chlorhexidine corresponds to 40,000mg/L) (12, 14, 18, 41) . However, the data 332 could still be of concern due to the low chlorhexidine concentrations occurring in 333 different environments (e.g. residual skin concentrations are variable according to 334 chlorhexidine baths procedures: 18.75-387.1 mg/L; sewage: <1 mg/L) (42-44), or 335 bacteria could better adapt in specific conditions (e.g. acid pH, starvation) (40, 45), 336 increasing their probability of survival under chlorhexidine stress. As in the case of 337 other antimicrobials (e.g. antibiotics, ethanol) (46), a prudent use of chlorhexidine (e.g. 338 standard protocols with sufficient exposure times and concentrations; control of its 339 release to the environment) is important to maintain its efficacy. 340
341

MATERIALS AND METHODS 342
Bacterial isolates epidemiological background. 343
One hundred and six E. faecium isolates obtained in Portugal, Spain, Angola, Canada, 344 Germany, and Tunisia (1995-2016) during previous surveillance studies were included 345 (11, (47) (48) (49) (50) (51) (52) (Table S1 
Study of chlorhexidine susceptibility 361
The minimum inhibitory concentration (MIC) and the minimum bactericidal 362 concentration (MBC) of chlorhexidine gluconate were determined by microdilution 363 (concentration range from 2 to 128 mg/L) using the methodological approach proposed 364 by Clinical and Laboratory Standards Institute methodology for antibiotic susceptibility 365 testing (Mueller-Hinton broth; pH=7.4; 37ºC/20h) (54) for the 106 E. faecium isolates. 366
The MIC was considered as the first dilution without visible growth after 20h of 367 incubation. The MBC corresponded to the lower chlorhexidine concentration in which 3 368 or less colonies were detected after the inoculation in Brain Heart Infusion agar with 10 369 μl (37ºC/48h) of each well without visible microbial growth, as described by CLSI for a 370 starting inoculum of 1 x 10 5 CFU/mL in exponential phase culture (55). Enterococcus 371 faecalis ATCC 29212 was used as control strain of chlorhexidine susceptibility, which 372 MIC and MBC were of 16 and 128 mg/L (56, this study), respectively. The assays were 373 repeated two to three times. The assessment of MIC wild type distribution was 374 performed using the ECOFFfinder tool (available at 375 http://www.eucast.org/mic_distributions_and_ecoffs/; ECOFFinder_XL_2010_V2.0) 376 (57), which attempts to fit a log-normal distribution to the presumptive wild type counts 377 by the so-called iterative statistical method. In order to detect differences in 378 chlorhexidine phenotypes distribution among E. faecium subpopulations, the 379 ECOFFinder tool was also applied to isolates from clades A1, A2 and B as separated 380 groups. The cutoff of 95% was chosen to set the limits of the wild type population, as 381 recommended by the guidelines of ECOFFinder tool in order to better detect tolerant 382 isolates. The NORM.DIST Excel's-16.19 function, the estimated mean, the standard 383 deviation and the cumulative normal distribution function option set to TRUE were also 384 used to calculate the probability of occurrence of isolates at the higher concentrations of 385 E. faecium population distribution and, consequently, the potential presence of an 386 acquired tolerance mechanism if such probability was too low (57). 387
As the skin pH ranges between 4 and 6 (39), we also performed a modified 388 microdilution assay using Mueller-Hinton broth adjusted to pH=5 (chlorhexidine-389 gluconate concentration range: 2-512 mg/L) to evaluate if a more acidic pH than that 390 used in standard conditions (7.4) could have an effect on E. faecium susceptibility to 391 chlorhexidine. This assay was performed in 37 whole-genome sequenced E. faecium Among the 106 E. faecium studied we selected 37 from different sources [clinical, 402 n=16 ; healthy human, n=2; long term care patients, n=1; animal production 403 (aquaculture, piggery, aviary), n=6; food of animal origin (bovine meat and milk, 404 poultry carcass, trout), n=9; aquatic environment (river), n=1; wild birds (rook, crow), 405 n=2] and clades (A1, n=19; A2, n=14; B, n=4) to study by whole genome sequence 406 (WGS). Moreover, such genomes corresponded to isolates exhibiting diverse 407 phenotypes to chlorhexidine (MIC ranging from <2 to 32 mg/L). Genomic DNA was 408 extracted (DNeasy Blood and Tissue Kit, Qiagen, Copenhagen, Denmark), with 409 subsequent library construction (Nextera Kit, Illumina, Little Chesterford, UK) and 410 finally WGS (Nextseq, Illumina, Little Chesterford, UK) according to the 411 manufacturer's instructions to obtain paired-end reads of 2*150 bp in length. Raw 412 sequencing data were analysed using the SerumQC pipeline (https://github.com/ssi-413 dk/SerumQC) to test the quality of the raw and pre-processed data. The SPAdes genome 414 assembler (58) version 3.10.0 was used for de novo assembling the paired-end reads; 415 and SerumQC for evaluating the quality of genome assembly. 416
The assembled genomes were screened for the presence of genes previously associated 417 with clorhexidine tolerance as chtR (coding for conserved DNA-binding response 418 regulator) and efrE (codifying for predicted ABC transport system) using BLASTN, and 419 BLASTP analysis was performed to compare the contigs with known sequences of the 420 NCBI database carrying P102H in the ChtR (reference strain was E. faecium E1162; 421
GenBank accession no. EFF34003.1; locus_tag EfmE1162_2203) and A290V in the 422 EfrE (reference strain was E. faecium 1,231,410; GenBank accession no. EEV54504.1; 423 locus_tag EFTG_02287) proteins, as described for chlorhexidine tolerant E. faecium 424 (21, 23). The 37 genomes were also searched for the presence of qac/smr genes 425 (qacA/B, qacEdelta, qacG, qacJ, qacZ, two smr) previously described in Enterococcus 426 and other Gram-positive bacteria (27) . A database with the qac genes sequences was 427 constructed (GenBank accession no. KM083808.1; HG934082.1; NG_048046.1 428 Y16944.1; HE579074.1; HQ663849.2; GQ900434.1) and genes were tested in our 429 sequenced genomes using the MyDBfinder tool available at Center for Genomic 430 Epidemiology (www.genomicepidemiology.org). 431 DOOR 2.0 software (http://csbl.bmb.uga.edu/DOOR/) was used to predict the 2CS 432 operon and respective promoter associated with chtR and chtS genes, previously 433 described by . The information related to each gene product 434 was retrieved from NCBI and PATRIC databases. Comparisons of the amino acid 435 sequences of each operon protein and nucleotide sequences of the predicted promoter 436 were performed with clustalW software (https://www.genome.jp/tools-bin/clustalw) 437 between the reference strain E. faecium E1162 and our sequenced E. faecium for the 438 identification of specific mutations. 439 440
Comparative genomics 441
The occurrence of ChtR-P102H and ErfE-A290V mutations was also searched in the E. 442 faecium genomes available at the GenBank databases (n=794, last update, 1 st December 443 2018). The ST/clade of these strains was inferred by interrogating the Center of 444 Genomic Epidemiology (www.genomicepidemiology.org) using the in silico genomic 445 MLST tool. Only genomes with a single amino acid change at 102 amino acid on the 446 ChtR protein (H102 or P102) were selected for this analysis. As the EfrE-A290V 447 mutation was only identified in lab mutants (23) 
A1
Hospital ( The operon and the respective promoter were predicted by DOOR 2.0 software in this study. The reference strain used was E. faecium E1162 718 (GenBank accession no. NZ_ABQJ01000097.1) previously classified as chlorhexidine tolerant (21 
Number of isolates
